These findings suggest that exosome-derived salivary miRNA could serve as a reliable and, most importantly, non-invasive evaluation tool of prostate cancer screening results (e.g., PSA serum measurements) under the concept of liquid biopsy [59]. The gene discussed is KLK3; the disease is Familial prostate cancer.